
Seventy-two organizations submitted a letter to the Drug Enforcement Administration asking for a permanent waiver of the requirement that patients be evaluated in person before being prescribed controlled substances via telemedicine.
The American Psychiatric Association, the American Telemedicine Association and ATA Action convened the collection of organizations.
According to an APA press release, the DEA is currently developing the Special Registration process for telemedicine use to prescribe controlled substances under the Ryan Haight Act. The agency waived this requirement during the